FENC
Fennec Pharmaceuticals (FENC)
$78
About Fennec Pharmaceuticals (FENC)
Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Details
Daily high
$13.25
Daily low
$11.61
Price at open
$12.16
52 Week High
$13.25
52 Week Low
$5.65
Market cap
380.0M
Dividend yield
0.00%
Volume
719,681
Avg. volume
142,694
P/E ratio
-36.93
Fennec Pharmaceuticals News
Details
Daily high
$13.25
Daily low
$11.61
Price at open
$12.16
52 Week High
$13.25
52 Week Low
$5.65
Market cap
380.0M
Dividend yield
0.00%
Volume
719,681
Avg. volume
142,694
P/E ratio
-36.93